Champions Oncology Inc (CSBR) — Cash Flow Reinvestment Rate

Latest as of July 2025: 0.15x

Champions Oncology Inc (CSBR) has a Cash Flow Reinvestment Rate of 0.15x as of July 2025, reinvesting $92.00K (capex $46.00K plus investments $-46.00K) from operating cash flow of $600.00K. Explore Champions Oncology Inc (CSBR) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.15x
(Capex + Investments) / Operating CF

Total Reinvested

$92.00K
Capex + Investments

Operating Cash Flow

$600.00K
USD

Capital Expenditures

$46.00K
USD

Champions Oncology Inc Cash Flow Reinvestment Rate (1997–2025)

Historical reinvestment intensity for Champions Oncology Inc across 10 annual periods. Also explore total assets of Champions Oncology Inc for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Champions Oncology Inc (1997–2025)

Year-by-year capital reinvestment analysis for Champions Oncology Inc. For live market cap and broader valuation context, see market value of Champions Oncology Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.11x $778.00K $7.39 Million $389.00K ▼ -92.7%
2023 1.45x $5.74 Million $3.96 Million $2.87 Million ▲ +97.9%
2022 0.73x $4.77 Million $6.50 Million $2.38 Million ▼ -52.0%
2020 1.53x $4.44 Million $2.90 Million $2.22 Million ▲ +70.6%
2019 0.90x $1.67 Million $1.86 Million $834.00K
2008 0.00x $0.00 $792.40K $0.00 ▼ -100.0%
2001 0.23x $33.72K $144.68K $33.72K ▲ +156.4%
1999 0.09x $10.00K $110.00K $10.00K ▲ +90.9%
1998 0.05x $20.00K $420.00K $20.00K ▼ -47.6%
1997 0.09x $10.00K $110.00K $10.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow